Company Performance - Celanese reported quarterly earnings of $1.44 per share, exceeding the Zacks Consensus Estimate of $1.38 per share, but down from $2.38 per share a year ago, indicating an earnings surprise of +4.35% [1] - The company posted revenues of $2.53 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.42%, although this is a decrease from year-ago revenues of $2.65 billion [2] - Over the last four quarters, Celanese has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] Stock Performance - Celanese shares have declined approximately 30.6% since the beginning of the year, contrasting with the S&P 500's gain of 8.6% [3] - The current Zacks Rank for Celanese is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $1.77 on revenues of $2.54 billion, and for the current fiscal year, it is $5.13 on revenues of $9.85 billion [7] - The outlook for the Chemical - Specialty industry, where Celanese operates, is currently in the bottom 35% of over 250 Zacks industries, which may impact the stock's performance [8]

Core Viewpoint - Getty Images Holdings, Inc. reported a quarterly loss of $0.08 per share, missing the Zacks Consensus Estimate of $0.03, and showing a significant decline from earnings of $0.01 per share a year ago, resulting in an earnings surprise of -366.67% [1][2] Financial Performance - The company posted revenues of $234.88 million for the quarter ended June 2025, which was 0.61% below the Zacks Consensus Estimate, but an increase from $229.14 million in the same quarter last year [2] - Over the last four quarters, Getty Images has not surpassed consensus EPS estimates and has only topped revenue estimates twice [2] Stock Performance - Shares of Getty Images have declined approximately 21.8% since the beginning of the year, contrasting with the S&P 500's gain of 8.6% [3] - The current Zacks Rank for Getty Images is 3 (Hold), indicating that the stock is expected to perform in line with the market in the near future [6] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is $0.03 on revenues of $242.78 million, while the estimate for the current fiscal year is -$0.16 on revenues of $952.28 million [7] - The trend of earnings estimate revisions is mixed, which could change following the recent earnings report [6] Industry Context - The Internet - Software industry, to which Getty Images belongs, is currently ranked in the top 37% of over 250 Zacks industries, suggesting that companies in the top half tend to outperform those in the bottom half by more than 2 to 1 [8]

Core Insights - Perion Network (PERI) reported quarterly earnings of $0.26 per share, exceeding the Zacks Consensus Estimate of $0.17 per share, with an earnings surprise of +52.94% [1] - The company posted revenues of $102.98 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.49%, although this represents a decline from year-ago revenues of $108.69 million [2] - Perion Network shares have increased approximately 20.5% year-to-date, outperforming the S&P 500's gain of 8.6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.26 on revenues of $110.5 million, and for the current fiscal year, it is $0.99 on revenues of $440.66 million [7] - The estimate revisions trend for Perion Network was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Internet - Content industry, to which Perion Network belongs, is currently ranked in the top 41% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Similarweb (SMWB), another company in the same industry, is expected to report a quarterly loss of $0.00 per share, with revenues projected at $68.88 million, reflecting a year-over-year increase of 13.6% [9]

Core Insights - Clearside Biomedical, Inc. reported a quarterly loss of $0.06 per share, outperforming the Zacks Consensus Estimate of a loss of $0.12, marking a 50% earnings surprise [1] - The company achieved revenues of $0.49 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 87.07%, compared to revenues of $0.09 million a year ago [2] - The stock has underperformed, losing approximately 59.7% since the beginning of the year, while the S&P 500 has gained 7.8% [3] Financial Performance - Over the last four quarters, Clearside Biomedical has surpassed consensus EPS estimates four times [2] - The current consensus EPS estimate for the upcoming quarter is -$0.08 on revenues of $0.26 million, and for the current fiscal year, it is -$0.38 on revenues of $3.22 million [7] Market Outlook - The company's earnings outlook is crucial for assessing future stock performance, with a favorable trend in estimate revisions leading to a Zacks Rank 2 (Buy) [6] - The Medical - Biomedical and Genetics industry is currently ranked in the bottom 43% of over 250 Zacks industries, which may impact stock performance [8]

What's Next for ProFrac Holding Corp.? While ProFrac Holding Corp. has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a str ...

Core Viewpoint - Arcosa (ACA) reported quarterly earnings of $1.27 per share, exceeding the Zacks Consensus Estimate of $1.05 per share, and showing an increase from $0.91 per share a year ago [1][2] Financial Performance - The earnings surprise for the quarter was +20.95%, with the company previously expected to earn $0.29 per share but actually earning $0.49, resulting in a surprise of +68.97% [2] - Arcosa's revenues for the quarter were $736.9 million, which missed the Zacks Consensus Estimate by 2.09%, compared to $664.7 million in the same quarter last year [3] - Over the last four quarters, the company has surpassed consensus EPS estimates three times but has only topped revenue estimates once [3] Stock Performance - Arcosa shares have declined approximately 12.5% since the beginning of the year, while the S&P 500 has gained 7.9% [4] - The company's current Zacks Rank is 3 (Hold), indicating expected performance in line with the market in the near future [7] Future Outlook - The consensus EPS estimate for the upcoming quarter is $1.32 on revenues of $778.3 million, and for the current fiscal year, it is $3.83 on revenues of $2.93 billion [8] - The outlook for the industry, specifically the Building Products - Miscellaneous sector, is currently in the bottom 37% of over 250 Zacks industries, which may impact stock performance [9]

Company Performance - Karat Packing (KRT) reported quarterly earnings of $0.57 per share, missing the Zacks Consensus Estimate of $0.60 per share, but showing an increase from $0.49 per share a year ago, resulting in an earnings surprise of -5.00% [1] - The company posted revenues of $123.99 million for the quarter ended June 2025, slightly missing the Zacks Consensus Estimate by 0.01%, and an increase from $112.6 million year-over-year [2] - Over the last four quarters, Karat Packing has surpassed consensus EPS estimates only once [2] Stock Outlook - The stock has underperformed the market, losing about 10.9% since the beginning of the year, while the S&P 500 gained 7.9% [3] - The current consensus EPS estimate for the coming quarter is $0.45 on revenues of $125 million, and for the current fiscal year, it is $1.59 on revenues of $462 million [7] Industry Context - The Containers - Paper and Packaging industry, to which Karat Packing belongs, is currently ranked in the bottom 21% of over 250 Zacks industries, indicating a challenging environment [8] - Empirical research suggests that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

Company Performance - Vermilion Energy reported a quarterly loss of $0.2 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.06, representing an earnings surprise of -233.33% [1] - The company posted revenues of $320.77 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 26.71%, and down from $350.04 million a year ago [2] - Over the last four quarters, Vermilion has not surpassed consensus EPS estimates and has topped revenue estimates only once [2] Stock Movement and Outlook - Vermilion shares have declined approximately 16.4% since the beginning of the year, contrasting with the S&P 500's gain of 7.9% [3] - The company's earnings outlook is crucial for understanding future stock performance, with current consensus EPS estimates at $0.07 for the coming quarter and $0.29 for the current fiscal year [4][7] Industry Context - The Oil and Gas - Exploration and Production - International industry, to which Vermilion belongs, is currently ranked in the bottom 18% of over 250 Zacks industries, indicating potential challenges ahead [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Vermilion's stock performance [5]

Company Performance - Verastem reported a quarterly loss of $0.39 per share, which was better than the Zacks Consensus Estimate of a loss of $0.85, representing an earnings surprise of +54.12% [1] - The company posted revenues of $2.14 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 86.36%, compared to revenues of $10 million a year ago [2] - Over the last four quarters, Verastem has surpassed consensus EPS estimates two times but has not beaten consensus revenue estimates [2] Stock Movement and Outlook - Verastem shares have increased by approximately 10.6% since the beginning of the year, outperforming the S&P 500's gain of 7.9% [3] - The future stock price movement will largely depend on management's commentary during the earnings call and the company's earnings outlook [4][6] - The current consensus EPS estimate for the upcoming quarter is -$0.72 on revenues of $10.98 million, and for the current fiscal year, it is -$3.51 on revenues of $17.25 million [7] Industry Context - The Medical - Biomedical and Genetics industry, to which Verastem belongs, is currently ranked in the top 41% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Verastem's performance [5]

Company Performance - Chesapeake Utilities reported quarterly earnings of $1.04 per share, exceeding the Zacks Consensus Estimate of $1 per share, and up from $0.86 per share a year ago, representing an earnings surprise of +4.00% [1] - The company posted revenues of $192.8 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.99%, compared to $166.27 million in the same quarter last year [2] - Over the last four quarters, Chesapeake Utilities has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Market Performance - Chesapeake Utilities shares have declined approximately 0.7% since the beginning of the year, while the S&P 500 has gained 7.9% [3] - The company's current Zacks Rank is 3 (Hold), indicating that shares are expected to perform in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.88 on revenues of $162.9 million, and for the current fiscal year, it is $6.27 on revenues of $885.2 million [7] - The outlook for the Utility - Gas Distribution industry is positive, currently ranking in the top 20% of over 250 Zacks industries, suggesting that the industry is likely to outperform the bottom 50% by a factor of more than 2 to 1 [8]